Quick view: BMW launches M6 Gran Coupe for Rs 1.75 crore

Apr 04 2014, 04:26 IST
Comments 0
SummaryGerman luxury carmaker BMW on Thursday launched an all-new version of its M6 Gran Coupe, a four-door sports car, priced at R1.75 crore

BMW launches M6 Gran Coupe for R1.75 crore

German luxury carmaker BMW on Thursday launched an all-new version of its M6 Gran Coupe, a four-door sports car, priced at R1.75 crore (ex-showroom, Delhi). Available as a completely built unit, the M6 Gran Coupe is powered by a 4.4-litre V8 engine and the 1.8-tonne car goes from 0-100 kmph in 4.2 seconds.

Adani Power pips Tata as largest pvt producer in India

Adani Power has emerged as the largest private power producer in India with an overall installed capacity of 8,620 MW, beating rival Tata Power which has gross installed capacity of 8,560 MW. The new capacity high has been reached with the commissioning of the fourth unit of 660 MW at its power plant at Tiroda in Maharashtra.

Tata fund to invest R300 cr in Varroc Engineering

Tata Capital's private equity Tata Opportunities Fund has picked up a minority stake in Aurangabad-based auto component manufacturer Varroc Engineering by investing R300 crore . The manufacturer that reported revenues of around R7,500 crore in fiscal 2013 would utilise funds for capex and reducing long term debt. Varroc founder and MD Tarang Jain said: "The Tata fund will not only bolster us financially but also provide us a strategic spring-board which will enable us to leapfrog into the next cycle of our growth.”

Tata Power to add 850 MW of generation capacity

Tata Power said on Thursday it will increase its generation capacity by 849.2 MW which will see its gross installed capacity touching about 9,400 MW. The company has eight solar, wind, hydro and gas-based projects in India and abroad under execution. Its under-execution projects include two wind power plants in South Africa, set to be commissioned in FY17.

Human trials for Glenmark Pharma’s pain drug

Glenmark Pharmaceuticals said on Thursday its experimental pain drug, dubbed GRC 27864, will enter human trials. The drug intends to be an improvement by removing gastrointestinal and cardiovascular side effects seen in currently approved pain-relief therapies. The company said it completed pre-clinical studies and filed an application for phase 1 studies with UKMHRA. Glenmark expects the phase 1 trial to be completed by January 2015.

Motilal Oswal’s realty fund invests R100 cr

India Realty Excellence Fund II, managed by Motilal Oswal Real Estate Investment Advisors, has announced two investments worth R100 crore in Mumbai with Ahuja Developers and another in Bangalore with Mahaveer Group.

The investments are in Ahuja's upcoming residential project

Single Page Format
Ads by Google

More from Front Page

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...